Long non-coding RNA CASC7 suppresses malignant behaviors of breast cancer by regulating miR-21-5p/FASLG axis

References

• Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2021. CA. 2021;71(1):7–33.
   Google Scholar
• Harbeck N, Penault-Llorca F, Cortes J, et al. Breast cancer. Nat Rev Dis Primers. 2019;5(1):66.
   PubMed Web of Science ®Google Scholar
• Lin F, Wang Z, Zhang K, et al. Contrast-enhanced spectral mammography-based radiomics nomogram for identifying benign and malignant breast lesions of Sub-1 cm. Front Oncol. 2020;10:573630.
   PubMed Web of Science ®Google Scholar
• Garrido-Castro AC, Lin NU, Polyak K. Insights into molecular classifications of triple-negative breast cancer: improving patient selection for treatment. Cancer Discov. 2019;9(2):176–198.
   PubMed Web of Science ®Google Scholar
• Crudele F, Bianchi N, Reali E, et al. The network of non-coding RNAs and their molecular targets in breast cancer. Mol Cancer. 2020;19(1):61.
   PubMed Web of Science ®Google Scholar
• Zhang X, Xie K, Zhou H, et al. Role of non-coding RNAs and RNA modifiers in cancer therapy resistance. Mol Cancer. 2020;19(1):47.
   PubMed Web of Science ®Google Scholar
• Smolarz B, Zadrożna-Nowak A, Romanowicz H. The role of lncRNA in the development of tumors, including breast cancer. Int J Mol Sci. 2021;22(16):8427.
   PubMed Web of Science ®Google Scholar
• Lennox KA, Behlke MA. Cellular localization of long non-coding RNAs affects silencing by RNAi more than by antisense oligonucleotides. Nucleic Acids Res. 2016;44(2):863–877.
   PubMed Web of Science ®Google Scholar
• Sun W, Yin D. Long noncoding RNA CASC7 inhibits the proliferation and migration of papillary thyroid cancer cells by inhibiting miR-34a-5p. J Physiol Sci. 2021;71(1):9.
   PubMed Web of Science ®Google Scholar
• Chen L, Li X, Lu C, et al. The long non‑coding RNA CASC7 inhibits growth and invasion of non‑small cell lung cancer cells through phosphatase and tensin homolog upregulation via sequestration of miR‑92a. Int J Oncol. 2020;57(2):466–477.
   PubMed Web of Science ®Google Scholar
• Xu YL, Liu Y, Cai R-P, et al. Long non-coding RNA CASC7 is associated with the pathogenesis of heart failure via modulating the expression of miR-30c. J Cell Mol Med. 2020;24(19):11500–11511.
   PubMed Web of Science ®Google Scholar
• Liu JH, Li C, Zhang C-H, et al. LncRNA-CASC7 enhances corticosteroid sensitivity via inhibiting the PI3K/AKT signaling pathway by targeting miR-21 in severe asthma. Pulmonology. 2020;26(1):18–26.
   PubMed Web of Science ®Google Scholar
• Liu B, Xiang W, Liu J, et al. The regulatory role of antisense lncRNAs in cancer. Cancer Cell Int. 2021;21(1):459.
   PubMed Web of Science ®Google Scholar
• Ojha R, Nandani R, Chatterjee N, et al. Emerging role of circular RNAs as potential biomarkers for the diagnosis of human diseases. Adv Exp Med Biol. 2018;1087:141–157.
   PubMed Web of Science ®Google Scholar
• Ma Y, Zhang J, Wen L, et al. Membrane-lipid associated lncRNA: a new regulator in cancer signaling. Cancer Lett. 2018;419:27–29.
   PubMed Web of Science ®Google Scholar
• Qin S, Ning M, Liu Q, et al. Knockdown of long non-coding RNA CDKN2B-AS1 suppresses the progression of breast cancer by miR-122-5p/STK39 axis. Bioengineered. 2021;12(1):5125–5137.
   PubMed Web of Science ®Google Scholar
• Jenike AE, Halushka MK. miR-21: a non-specific biomarker of all maladies. Biomark Res. 2021;9(1):18.
   PubMed Web of Science ®Google Scholar
• Zhang L, Yu L, Liu Y, et al. miR-21-5p promotes cell proliferation by targeting BCL11B in Thp-1 cells. Oncol Lett. 2021;21(2):119.
   PubMed Web of Science ®Google Scholar
• Song J, Yang P, Li X, et al. Esophageal cancer-derived extracellular vesicle miR-21-5p contributes to EMT of ESCC cells by disorganizing macrophage polarization. Cancers (Basel). 2021;13(16):4122.
   PubMed Web of Science ®Google Scholar
• Tang J, Li X, Cheng T, et al. miR-21-5p/SMAD7 axis promotes the progress of lung cancer. Thorac Cancer. 2021;12:2307–2313.
   PubMed Web of Science ®Google Scholar
• Cao J, Zhang Y, Mu J, et al. Exosomal miR-21-5p contributes to ovarian cancer progression by regulating CDK6. Hum Cell. 2021;34(4):1185–1196.
   PubMed Web of Science ®Google Scholar
• Xie Y, Liu Y, Fan X, et al. MicroRNA-21 promotes progression of breast cancer via inhibition of mitogen-activated protein kinase10 (MAPK10). Biosci Rep. 2019 Aug 2; BSR20181000 .
   Google Scholar
• Magerus A, Bercher-Brayer C, Rieux-Laucat F. The genetic landscape of the FAS pathway deficiencies. Biomed J. 2021;44:388–399.
   PubMed Web of Science ®Google Scholar
• Liu Y, Wen Q-J, Yin Y, et al. FASLG polymorphism is associated with cancer risk. Eur J Cancer. 2009;45(14):2574–2578.
   PubMed Web of Science ®Google Scholar
• Kadam CY, Abhang SA. Apoptosis markers in breast cancer therapy. Adv Clin Chem. 2016;74:143–193.
   PubMed Web of Science ®Google Scholar
• Gong X, Liao X, Huang M. LncRNA CASC7 inhibits the progression of glioma via regulating Wnt/β-catenin signaling pathway. Pathol Res Pract. 2019;215(3):564–570.
   PubMed Web of Science ®Google Scholar
• Zhou X, Lu H, Li F, et al. LncRNA cancer susceptibility candidate (CASC7) upregulates phosphatase and tensin homolog by downregulating miR-10a to inhibit neuroblastoma cell proliferation. Neuroreport. 2020;31(5):381–386.
   PubMed Web of Science ®Google Scholar
• Banerjee S, Kalyani Yabalooru SR, Karunagaran D. Identification of mRNA and non-coding RNA hubs using network analysis in organ tropism regulated triple negative breast cancer metastasis. Comput Biol Med. 2020;127:104076.
   PubMed Web of Science ®Google Scholar
• Gholaminejad A, Abdul Tehrani H, Gholami Fesharaki M. Identification of candidate microRNA biomarkers in diabetic nephropathy: a meta-analysis of profiling studies. J Nephrol. 2018;31(6):813–831.
   PubMed Web of Science ®Google Scholar
• Li X, Wu X. MiR-21-5p promotes the progression of non-small-cell lung cancer by regulating the expression of SMAD7. Onco Targets Ther. 2018;11:8445–8454.
   PubMed Web of Science ®Google Scholar
• Prager I, Watzl C. Mechanisms of natural killer cell-mediated cellular cytotoxicity. J Leukoc Biol. 2019;105(6):1319–1329.
   PubMed Web of Science ®Google Scholar